Loop diuretics in chronic heart failure therapy and functional disorders of bone tissue

Ignatyev, O. M.; Panyuta, O. I.

dc.contributor.author	Ignatyev, O. M.	en
dc.contributor.author	Panyuta, O. I.	en
dc.date.accessioned	2025-04-24T11:32:59Z
dc.date.available	2025-04-24T11:32:59Z
dc.date.issued	2025
dc.identifier.citation	Ignatyev O. M., Panyuta O. I. Loop diuretics in chronic heart failure therapy and functional disorders of bone tissue // World congress on osteoporosis, osteoarthritis and musculoskeletal diseases, April 10–13, 2025. Rome, Italy. 2025. P1159. P. 724–725.	en
dc.identifier.uri	https://repo.odmu.edu.ua:443/xmlui/handle/123456789/17381
dc.description.abstract	In the most countries the prevalence of chronic heart failure (CHF) among the adult population in general 1.5–5.5%. According to epidemiological data, almost 75–80% of all cases of CHF are caused by coronary heart disease (CHD) or arterial hypertension (AH) by itself or in combination. The purpose of the study was to assess the effect of loop diuretic therapy on phosphorus-calcium metabolism in patients with chronic heart failure and moderately reduced ejection fraction.	uk_UA
dc.language.iso	en	en
dc.subject	Loop diuretics	en
dc.subject	chronic heart failure therapy	en
dc.subject	functional disorders of bone tissue	en
dc.title	Loop diuretics in chronic heart failure therapy and functional disorders of bone tissue	en
dc.type	Article	en